Evaluating oral nutritional support and the nutritional risk scores in ICI-treated metastatic solid tumours

Key Points

• The study aims to assess the impact of oral nutritional support on survival and the efficacy of nutritional risk scores in patients treated with immune checkpoint inhibitors.
• Prospective evaluation of nutritional support in metastatic patients receiving ICIs
• Assessment of survival rates and immune-related adverse events (irAEs)
• Use of nutritional risk scores for prognostic stratification
• Oral nutritional support did not improve survival outcomes or rates of irAEs
• Nutritional risk scores showed strong capabilities for prognostic stratification
• Further research is needed on integrated approaches to nutrition and cachexia therapy